Portal:CPTAC/Hallmarks

From WikiPathways

(Difference between revisions)
Jump to: navigation, search
Current revision (18:59, 5 October 2017) (view source)
(added Therapeutics category)
 
(6 intermediate revisions not shown.)
Line 1: Line 1:
-
{| style="margin: 10px; background-color:#eaf2ee"
+
{| style="width:100%; margin: 10px; background-color:#eaf2ee"
-
|width=100px; cell padding=50px; style="text-align:center;"|'''Sustaining proliferative signaling''' {{ #pathwayOfTheDay: {{LOCALDAYNAME}} {{LOCALDAY}} {{LOCALMONTHNAME}} {{LOCALYEAR}} | Portal:CPTAC/Hallmark/Proliferative}} View all [[Portal:CPTAC/Hallmark/Proliferative|hallmark pathways]]
+
|width=100px; cell padding=50px; style="text-align:center;"|[[Portal:CPTAC/Hallmark/Proliferative|<big><u><b>Sustaining proliferative signaling</b></u></big>]] {{ #pathwayOfTheDay: {{LOCALDAYNAME}} {{LOCALDAY}} {{LOCALMONTHNAME}} {{LOCALYEAR}} | Portal:CPTAC/Hallmark/Proliferative}}
-
|width=100px; style="text-align:center;"|'''Evading growth suppressors'''{{#pwImage:Pathway:WP3972|250px||PDGFR-beta pathway}}
+
|width=100px; style="text-align:center;"|[[Portal:CPTAC/Hallmark/Growth|<big><u><b>Evading growth suppressors</b></u></big>]] {{ #pathwayOfTheDay: {{LOCALDAYNAME}} {{LOCALDAY}} {{LOCALMONTHNAME}} {{LOCALYEAR}} | Portal:CPTAC/Hallmark/Growth}}
-
|width=100px; style="text-align:center;"|'''Activating invasion and metastasis''' {{#pwImage:Pathway:WP2828|250px||Bladder Cancer}}
+
|width=100px; style="text-align:center;"|[[Portal:CPTAC/Hallmark/Invasion|<big><u><b>Activating invasion and metastasis</b></u></big>]] {{ #pathwayOfTheDay: {{LOCALDAYNAME}} {{LOCALDAY}} {{LOCALMONTHNAME}} {{LOCALYEAR}} | Portal:CPTAC/Hallmark/Invasion}}
-
|width=100px; style="text-align:center;"|'''Enabling replicative immortality''' {{#pwImage:Pathway:WP581|250px||EPO Receptor Signaling}}
+
|-
|-
-
|width=100px|{{#pwImage:Pathway:WP673|250px||ErbB Signaling Pathway}}
+
|width=100px; style="text-align:center;"|[[Portal:CPTAC/Hallmark/immortality|<big><u><b>Enabling replicative immortality</b></u></big>]] {{ #pathwayOfTheDay: {{LOCALDAYNAME}} {{LOCALDAY}} {{LOCALMONTHNAME}} {{LOCALYEAR}} | Portal:CPTAC/Hallmark/immortality}}
-
|width=100px|{{#pwImage:Pathway:WP585|250px||Interferon type I signaling pathways}}
+
|width=100px; style="text-align:center;"|[[Portal:CPTAC/Hallmark/Angiogenesis|<big><u><b>Inducing angiogenesis</b></u></big>]] {{ #pathwayOfTheDay: {{LOCALDAYNAME}} {{LOCALDAY}} {{LOCALMONTHNAME}} {{LOCALYEAR}} | Portal:CPTAC/Hallmark/Angiogenesis}}
-
|width=100px|{{#pwimage:Pathway:WP3|250px||Transcriptional activation by NRF2}}
+
|width=100px; style="text-align:center;"|[[Portal:CPTAC/Hallmark/Resisting|<big><u><b>Resisting cell death</b></u></big>]] {{ #pathwayOfTheDay: {{LOCALDAYNAME}} {{LOCALDAY}} {{LOCALMONTHNAME}} {{LOCALYEAR}} | Portal:CPTAC/Hallmark/Resisting}}
-
|width=100px|{{#pwimage:Pathway:WP4018|250px||Pathways in Renal Cancer}}
+
|-
 +
|width=100px; style="text-align:center;"|[[Portal:CPTAC/Hallmark/Deregulating|<big><u><b>Deregulating cellular energetics</b></u></big>]] {{ #pathwayOfTheDay: {{LOCALDAYNAME}} {{LOCALDAY}} {{LOCALMONTHNAME}} {{LOCALYEAR}} | Portal:CPTAC/Hallmark/Deregulating}}
 +
|width=100px; style="text-align:center;"|[[Portal:CPTAC/Hallmark/Instability|<big><u><b>Genome instability and mutation</b></u></big>]] {{ #pathwayOfTheDay: {{LOCALDAYNAME}} {{LOCALDAY}} {{LOCALMONTHNAME}} {{LOCALYEAR}} | Portal:CPTAC/Hallmark/Instability}}
 +
|width=100px; style="text-align:center;"|[[Portal:CPTAC/Hallmark/Inflammation|<big><u><b>Tumor promoting inflammation</b></u></big>]] {{ #pathwayOfTheDay: {{LOCALDAYNAME}} {{LOCALDAY}} {{LOCALMONTHNAME}} {{LOCALYEAR}} | Portal:CPTAC/Hallmark/Inflammation}}
 +
|-
 +
|width=100px; style="text-align:center;"|[[Portal:CPTAC/Hallmark/Avoiding|<big><u><b>Avoiding immune destruction</b></u></big>]] {{ #pathwayOfTheDay: {{LOCALDAYNAME}} {{LOCALDAY}} {{LOCALMONTHNAME}} {{LOCALYEAR}} | Portal:CPTAC/Hallmark/Avoiding}}
 +
|width=100px; style="text-align:center;"|[[Portal:CPTAC/Hallmark/Therapeutics|<big><u><b>Therapeutics</b></u></big>]] {{ #pathwayOfTheDay: {{LOCALDAYNAME}} {{LOCALDAY}} {{LOCALMONTHNAME}} {{LOCALYEAR}} | Portal:CPTAC/Hallmark/Therapeutics}}
|}
|}

Current revision

Sustaining proliferative signaling

EPO receptor signaling (Homo sapiens)

Image does not exist
EPO receptor signaling
Evading growth suppressors

Tumor suppressor activity of SMARCB1 (Homo sapiens)

Image does not exist
Tumor suppressor activity of SMARCB1
Activating invasion and metastasis

H19, Rb-E2F1, and CDK-beta-catenin in colorectal cancer (Homo sapiens)

Image does not exist
H19, Rb-E2F1, and CDK-beta-catenin in colorectal cancer
Enabling replicative immortality

ncRNAs involved in STAT3 signaling in hepatocellular carcinoma (Homo sapiens)

Image does not exist
ncRNAs involved in STAT3 signaling in hepatocellular carcinoma
Inducing angiogenesis

PDGF pathway (Homo sapiens)

Image does not exist
PDGF pathway
Resisting cell death

miRNA regulation of p53 pathway in prostate cancer (Homo sapiens)

Image does not exist
miRNA regulation of p53 pathway in prostate cancer
Deregulating cellular energetics

Fatty acid beta-oxidation (Homo sapiens)

Image does not exist
Fatty acid beta-oxidation
Genome instability and mutation

Chromosomal and microsatellite instability in colorectal cancer (Homo sapiens)

Image does not exist
Chromosomal and microsatellite instability in colorectal cancer
Tumor promoting inflammation

Cytokines and inflammatory response (Homo sapiens)

Image does not exist
Cytokines and inflammatory response
Avoiding immune destruction

Interferon type I signaling (Homo sapiens)

Image does not exist
Interferon type I signaling
Therapeutics

Photodynamic therapy-induced HIF-1 survival signaling (Homo sapiens)

Image does not exist
Photodynamic therapy-induced HIF-1 survival signaling
Personal tools